DE60013463D1 - Pharmazeutische produkte und verfahren zu deren herstellung - Google Patents

Pharmazeutische produkte und verfahren zu deren herstellung

Info

Publication number
DE60013463D1
DE60013463D1 DE60013463T DE60013463T DE60013463D1 DE 60013463 D1 DE60013463 D1 DE 60013463D1 DE 60013463 T DE60013463 T DE 60013463T DE 60013463 T DE60013463 T DE 60013463T DE 60013463 D1 DE60013463 D1 DE 60013463D1
Authority
DE
Germany
Prior art keywords
production
pharmaceutical products
pharmaceutical
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60013463T
Other languages
English (en)
Other versions
DE60013463T2 (de
Inventor
Leigh Trevor Canham
Guy Sapsford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psimedica Ltd
Original Assignee
Psimedica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psimedica Ltd filed Critical Psimedica Ltd
Application granted granted Critical
Publication of DE60013463D1 publication Critical patent/DE60013463D1/de
Publication of DE60013463T2 publication Critical patent/DE60013463T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0097Micromachined devices; Microelectromechanical systems [MEMS]; Devices obtained by lithographic treatment of silicon; Devices comprising chips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60013463T 1999-10-15 2000-10-11 Pharmazeutische produkte und verfahren zu deren herstellung Expired - Lifetime DE60013463T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9924334.7A GB9924334D0 (en) 1999-10-15 1999-10-15 Pharmaceutical products and methods of fabrication therefor
GB9924334 1999-10-15
PCT/GB2000/003894 WO2001028529A1 (en) 1999-10-15 2000-10-11 Pharmaceutical products and methods of fabrication therefor

Publications (2)

Publication Number Publication Date
DE60013463D1 true DE60013463D1 (de) 2004-10-07
DE60013463T2 DE60013463T2 (de) 2005-09-15

Family

ID=10862740

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60013463T Expired - Lifetime DE60013463T2 (de) 1999-10-15 2000-10-11 Pharmazeutische produkte und verfahren zu deren herstellung

Country Status (8)

Country Link
EP (1) EP1220659B1 (de)
JP (1) JP5031161B2 (de)
AU (1) AU771329B2 (de)
CA (1) CA2388731C (de)
DE (1) DE60013463T2 (de)
ES (1) ES2225229T3 (de)
GB (1) GB9924334D0 (de)
WO (1) WO2001028529A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808052D0 (en) 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
GB2365769A (en) * 2000-08-18 2002-02-27 Secr Defence Skin preparations containing silicon
ITTO20030409A1 (it) * 2003-06-03 2004-12-04 Fiat Ricerche Biosensore ottico.
US7981441B2 (en) 2004-02-18 2011-07-19 The Board Of Trustees Of The Leland Stanford Junior University Drug delivery systems using mesoporous oxide films
US8097269B2 (en) 2004-02-18 2012-01-17 Celonova Biosciences, Inc. Bioactive material delivery systems comprising sol-gel compositions
DE102004034355B4 (de) * 2004-07-13 2007-03-22 Fachhochschule Jena Kapsel zum Freisetzen von in ihr befindlichen Wirksoffen an definierten Orten in einem Körper
GB2418144A (en) * 2004-09-17 2006-03-22 Psimedica Ltd Medical device for delivery of beneficial substance
GB0526332D0 (en) * 2005-12-23 2006-02-01 Psimedica Ltd Pharmaceutical product
NZ594136A (en) 2006-06-15 2013-03-28 Seagull Ip Pty Ltd Delivery of bound material from body to surface using ultrasonic signal
DE102006031758A1 (de) * 2006-07-04 2008-01-10 Kilic, Cuma Zusammensetzung zur Verminderung der Eindringtiefe von Körperflüssigkeiten in die Harnröhre
US9114125B2 (en) 2008-04-11 2015-08-25 Celonova Biosciences, Inc. Drug eluting expandable devices
EP2427179A4 (de) 2009-05-04 2013-09-11 Psivida Inc Poröse partikel zur freisetzung von silicium-arzneimitteln
IN2013MN00758A (de) 2010-11-01 2015-06-12 Psivida Inc
JP2016512839A (ja) 2013-03-15 2016-05-09 シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. 治療物質の送達のための生体内分解性ケイ素系組成物
CN113262204A (zh) 2016-01-29 2021-08-17 株式会社Kit 固体制剂、固体制剂的制备方法及析氢方法
JP6916184B2 (ja) 2016-08-23 2021-08-11 株式会社Kit 配合物の製造方法
WO2018037818A1 (ja) 2016-08-23 2018-03-01 小林 光 水素供給材及びその製造方法、並びに水素供給方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9611437D0 (en) * 1995-08-03 1996-08-07 Secr Defence Biomaterial
AU1194697A (en) * 1995-12-21 1997-07-17 Quest International B.V. Particle compositions
US5797898A (en) * 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
SE9704400D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Porous inorganic particles as carriers for drug substances
GB9808052D0 (en) * 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants

Also Published As

Publication number Publication date
JP5031161B2 (ja) 2012-09-19
CA2388731A1 (en) 2001-04-26
WO2001028529A1 (en) 2001-04-26
ES2225229T3 (es) 2005-03-16
AU7802900A (en) 2001-04-30
GB9924334D0 (en) 1999-12-15
EP1220659A1 (de) 2002-07-10
DE60013463T2 (de) 2005-09-15
AU771329B2 (en) 2004-03-18
EP1220659B1 (de) 2004-09-01
CA2388731C (en) 2009-08-18
JP2003512318A (ja) 2003-04-02

Similar Documents

Publication Publication Date Title
ATE370946T1 (de) 16-halogen-epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung
DE69941054D1 (de) Isosorbid enthaltende poyester und verfahren zu deren herstellung
DE60035576D1 (de) Gefrorene milchprodukte und verfahren zu deren herstellung
ATE307576T1 (de) Fenofibrathaltige arzneizusammensetzung mit erhöhter bioverfügbarkeit und verfahren zu deren herstellung
DE60039983D1 (de) In mikrotechnik hergestellter wandler und verfahren zu dessen herstellung
ATE279506T1 (de) Tabletten und verfahren zu deren herstellung
ATE551940T1 (de) Mehrschichtfolie und verfahren zu deren herstellung
DE60000478D1 (de) Mehrschichtige rfid etikettenanordnung und verfahren zu deren herstellung
DE60215851D1 (de) N-adamantylmethyl-derivate und zwischenprodukte als pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
DE69826317D1 (de) Progesterontablette und verfahren zu deren herstellung
DE69932361D1 (de) Trennschicht und verfahren zu deren herstellung
DE69942382D1 (de) Sensor und verfahren zu dessen herstellung
DE60013463D1 (de) Pharmazeutische produkte und verfahren zu deren herstellung
DE60017552D1 (de) Geschaeumte schokolade und verfahren zu dessen herstellung
ATE288577T1 (de) Ladeluftkühler und verfahren zu dessen herstellung
ATE241613T1 (de) Pyrimidinderivate und verfahren zu deren herstellung
DE69838065D1 (de) Aerosolprodukte und verfahren zu deren herstellung
ATE234103T1 (de) Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung
DE60037325D1 (de) Eine optoelektronische anordnung und verfahren zu deren herstellung
ATE370951T1 (de) Purinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE60020066D1 (de) Mehrschichtfolie und verfahren zu deren herstellung
DE69934781D1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
ATE294175T1 (de) 4-sulfonamid-piperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE60203178D1 (de) Pharmazeutische formulierung mit überdecktem geschmack und verfahren zu ihrer herstellung
ATE354356T1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition